Loading clinical trials...
Loading clinical trials...
The purpose of the study is to evaluate the safety and tolerability of DRG stimulation when placing a neurostimulator during the same procedure as implantation of spinal fixation with or without interbody cage systems in patients with chronic back and/or leg pain requiring single level spinal fusion.
Age
21 - 80 years
Sex
ALL
Healthy Volunteers
No
South Bend Orthopaedics
Mishawaka, Indiana, United States
University of Minnesota
Minneapolis, Minnesota, United States
Start Date
January 6, 2022
Primary Completion Date
October 1, 2024
Completion Date
October 1, 2024
Last Updated
November 24, 2023
20
ESTIMATED participants
DRG Neurostimulation with Spinal Fusion
DEVICE
Lead Sponsor
SynerFuse, Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06219408